Edition:
India

Keryx Biopharmaceuticals Inc (KERX.OQ)

KERX.OQ on NASDAQ Stock Exchange Capital Market

4.89USD
16 Feb 2018
Change (% chg)

$0.04 (+0.82%)
Prev Close
$4.85
Open
$4.84
Day's High
$4.92
Day's Low
$4.78
Volume
167,572
Avg. Vol
439,296
52-wk High
$8.37
52-wk Low
$4.02

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 18.68 -0.255
Sep '17 15.00 -0.197
Jun '17 15.14 -0.768
Mar '17 11.82 -0.215
FY 2016 Dec '16 9.53 -0.319
Sep '16 6.34 -0.394
Jun '16 9.29 -0.422
Mar '16 6.82 -0.388
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 4 21.90 24.33 19.00 27.98
Quarter Ending Jun-18 4 24.95 26.54 23.00 34.19
Year Ending Dec-18 7 118.34 177.60 100.00 124.09
Year Ending Dec-19 8 182.21 292.70 128.70 215.86
Earnings (per share)
Quarter Ending Mar-18 8 -0.18 -0.14 -0.25 0.03
Quarter Ending Jun-18 8 -0.16 -0.13 -0.22 0.06
Year Ending Dec-18 6 -0.60 -0.47 -0.81 -0.21
Year Ending Dec-19 7 -0.18 -0.03 -0.32 0.22
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 133.79 65.94 44.94
EPS (TTM) % -28.41 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Keryx Biopharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 66.66%
# of Holders: 182
Total Shares Held: 79,469,210
3 Mo. Net Change: -423,854
# New Positions: 24
# Closed Positions: 27
# Increased Positions: 76
# Reduced Positions: 68
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.